Scarica l'app Stockscreener
10.45
2.79%
-0.30
Precedente Chiudi:
$10.75
Aprire:
$10.8
Volume 24 ore:
159.84K
Relative Volume:
0.51
Capitalizzazione di mercato:
$554.79M
Reddito:
-
Utile/perdita netta:
$-83.74M
Rapporto P/E:
-6.4907
EPS:
-1.61
Flusso di cassa netto:
$-64.98M
1 W Prestazione:
+0.77%
1M Prestazione:
+5.45%
6M Prestazione:
-17.52%
1 anno Prestazione:
-48.62%
Intervallo 1D:
$10.21
$10.97
Intervallo di 1 settimana:
$10.00
$11.72
Portata 52W:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Nome
Tyra Biosciences Inc
Settore
Industria
Telefono
(619) 728-4760
Indirizzo
2656 STATE STREET, CARLSBAD
Confronta TYRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.45 | 586.55M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-21 | Ripresa | Piper Sandler | Overweight |
| 2025-01-07 | Iniziato | UBS | Buy |
| 2024-10-18 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-08-15 | Iniziato | Piper Sandler | Overweight |
| 2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-06-30 | Iniziato | Wedbush | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-03-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-11-08 | Downgrade | Jefferies | Buy → Hold |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
Full technical analysis of Tyra Biosciences Inc. stockFree Chart Driven High Reward Trading Setup - Newser
How to integrate Tyra Biosciences Inc. into portfolio analysis toolsFree Trend Analysis for Safer Trades - Newser
What machine learning models say about Tyra Biosciences Inc.Real-Time AI Sentiment and Price Forecast - Newser
Combining price and volume data for Tyra Biosciences Inc.AI Powered Buy Point Forecast Planner - Newser
Does Tyra Biosciences Inc. show high probability of reboundForecast Model for Intraday Buy Signals - Newser
What indicators show strength in Tyra Biosciences Inc.Volume Confirmed Setup with Entry Confidence - Newser
Will Tyra Biosciences Inc. see short term momentumPattern Breakout Prediction for Short Term - Newser
How institutional ownership impacts Tyra Biosciences Inc. stockEarly Entry Planner for Swing Candidates - Newser
Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight - Yahoo Finance
Visual trend scoring systems applied to Tyra Biosciences Inc.Buy and Hold Strategy for Capital Safety - Newser
Technical analysis overview for Tyra Biosciences Inc. stockChart Based Entry Tool for ROI Traders - Newser
Why Tyra Biosciences Inc. stock attracts strong analyst attentionEarly Entry Planner for Swing Candidates - Newser
News impact scoring models applied to Tyra Biosciences Inc.Tactical Trade Setup With Entry Optimizer - Newser
Bank of New York Mellon Corp Sells 3,924 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
What makes Tyra Biosciences Inc. stock attractive to long term investorsInvestment Roadmap for High Potential Stocks - Newser
Can Tyra Biosciences Inc. recover in the next quarterShort-Term Swing Opportunity Summary Sheet - Newser
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $28 - 富途牛牛
How Tyra Biosciences Inc. stock performs during market volatilityMachine Learning Stock Movement Detector - Newser
Relative strength of Tyra Biosciences Inc. in sector analysisFree Swing Trading Entry Point Signals - Newser
What are Tyra Biosciences Inc. company’s key revenue driversDiscover undervalued opportunities early - Jammu Links News
When is Tyra Biosciences Inc. stock expected to show significant growthDiscover undervalued stocks before they soar - Jammu Links News
Why is Tyra Biosciences Inc. stock attracting strong analyst attentionAchieve fast wealth growth with smart picks - Jammu Links News
What drives Tyra Biosciences Inc. stock priceRobust financial gains - Jammu Links News
What are the latest earnings results for Tyra Biosciences Inc.Overwhelming profit margins - Jammu Links News
How strong is Tyra Biosciences Inc. company’s balance sheetGet exclusive market analysis for investors - Jammu Links News
Should I hold or sell Tyra Biosciences Inc. stock in 2025Uncover the best stocks for explosive growth - Jammu Links News
Is Tyra Biosciences Inc. a growth stock or a value stockFree Wealth Planning Blueprint - Jammu Links News
What institutional investors are buying Tyra Biosciences Inc. stockExtraordinary performance - Jammu Links News
How does Tyra Biosciences Inc. generate profit in a changing economyGet real-time alerts on top stocks - Jammu Links News
Is it the right time to buy Tyra Biosciences Inc. stockFree Advanced Stock Screener Access - Jammu Links News
Published on: 2025-08-03 14:27:08 - Jammu Links News
Tyra Biosciences Inc. Stock Analysis and ForecastSkyrocketing investment returns - Jammu Links News
What is the risk reward ratio of investing in Tyra Biosciences Inc. stockDiscover market opportunities with expert help - Jammu Links News
What are analysts’ price targets for Tyra Biosciences Inc. in the next 12 monthsInvest confidently with market-leading analysis - Jammu Links News
Does Tyra Biosciences Inc. stock perform well during market downturnsDiscover top stock picks for aggressive growth - Jammu Links News
What moving averages say about Tyra Biosciences Inc.Reversal Pattern Insights with Entry Tips - Newser
What institutional flow reveals about Tyra Biosciences Inc.Free Access to Real-Time Trade Insights - Newser
How to recover losses in Tyra Biosciences Inc. stockDownside Risk Evaluation and Stock Analysis - Newser
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ - openPR.com
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ Emerging Therapies Target FGFR2, IDH1/2, and Beyond | DelveInsight - The Globe and Mail
Tyra Biosciences Inc Azioni (TYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tyra Biosciences Inc Azioni (TYRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KAPLAN GILLA | Director |
Jun 17 '25 |
Sale |
10.35 |
10 |
104 |
37,799 |
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):